Impact of Model-Informed Drug Development on Drug Development Cycle Times and Clinical Trial Cost

While the application of MIDD has grown, there have been no clear examples across programs to demonstrate its value at the portfolio level. This manuscript offers a methodology and examples to demonstrate MIDD value in terms of time and cost savings.